Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.

Genetic variation in the metabotropic glutamate receptor 3 (GRM3, mGluR3) has been associated with schizophrenia, but the mechanism by which it confers risk is unknown. Previously, we reported the existence of a splice variant, GRM3Delta4, which has an exon 4 deletion and encodes a truncated form of...

Full description

Bibliographic Details
Main Authors: Sartorius, L, Weinberger, DR, Hyde, T, Harrison, P, Kleinman, J, Lipska, B
Format: Journal article
Language:English
Published: 2008
_version_ 1797061997308674048
author Sartorius, L
Weinberger, DR
Hyde, T
Harrison, P
Kleinman, J
Lipska, B
author_facet Sartorius, L
Weinberger, DR
Hyde, T
Harrison, P
Kleinman, J
Lipska, B
author_sort Sartorius, L
collection OXFORD
description Genetic variation in the metabotropic glutamate receptor 3 (GRM3, mGluR3) has been associated with schizophrenia, but the mechanism by which it confers risk is unknown. Previously, we reported the existence of a splice variant, GRM3Delta4, which has an exon 4 deletion and encodes a truncated form of the receptor that is expressed in brain. The aim of the present study was to determine whether expression of this splice variant is altered in individuals with schizophrenia and is affected by a risk genotype. We measured GRM3 and GRM3Delta4 transcripts in human dorsolateral prefrontal cortex (DLPFC) and hippocampus of the CBDB/NIMH collection ( approximately 70 controls, approximately 30 schizophrenia patients) and in the DLPFC of the Stanley Array Collection. Expression data of GRM3 mRNA in the DLPFC were inconsistent: GRM3 was increased in schizophrenia patients in the CBDB/NIMH collection, but not in the Stanley Array Collection. GRM3 expression did not change in the frontal cortex of rats treated chronically with haloperidol or clozapine. An exon 3 SNP previously associated with schizophrenia (rs2228595) predicted increased expression of the GRM3Delta4 splice variant. Our results suggest that rs2228595, or a neighboring SNP in linkage disequilibrium with it, may contribute to risk for schizophrenia by modulating GRM3 splicing.
first_indexed 2024-03-06T20:39:13Z
format Journal article
id oxford-uuid:33b45464-940b-478c-9fbb-2ff17c12383b
institution University of Oxford
language English
last_indexed 2024-03-06T20:39:13Z
publishDate 2008
record_format dspace
spelling oxford-uuid:33b45464-940b-478c-9fbb-2ff17c12383b2022-03-26T13:21:42ZExpression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:33b45464-940b-478c-9fbb-2ff17c12383bEnglishSymplectic Elements at Oxford2008Sartorius, LWeinberger, DRHyde, THarrison, PKleinman, JLipska, BGenetic variation in the metabotropic glutamate receptor 3 (GRM3, mGluR3) has been associated with schizophrenia, but the mechanism by which it confers risk is unknown. Previously, we reported the existence of a splice variant, GRM3Delta4, which has an exon 4 deletion and encodes a truncated form of the receptor that is expressed in brain. The aim of the present study was to determine whether expression of this splice variant is altered in individuals with schizophrenia and is affected by a risk genotype. We measured GRM3 and GRM3Delta4 transcripts in human dorsolateral prefrontal cortex (DLPFC) and hippocampus of the CBDB/NIMH collection ( approximately 70 controls, approximately 30 schizophrenia patients) and in the DLPFC of the Stanley Array Collection. Expression data of GRM3 mRNA in the DLPFC were inconsistent: GRM3 was increased in schizophrenia patients in the CBDB/NIMH collection, but not in the Stanley Array Collection. GRM3 expression did not change in the frontal cortex of rats treated chronically with haloperidol or clozapine. An exon 3 SNP previously associated with schizophrenia (rs2228595) predicted increased expression of the GRM3Delta4 splice variant. Our results suggest that rs2228595, or a neighboring SNP in linkage disequilibrium with it, may contribute to risk for schizophrenia by modulating GRM3 splicing.
spellingShingle Sartorius, L
Weinberger, DR
Hyde, T
Harrison, P
Kleinman, J
Lipska, B
Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title_full Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title_fullStr Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title_full_unstemmed Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title_short Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
title_sort expression of a grm3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk snp
work_keys_str_mv AT sartoriusl expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp
AT weinbergerdr expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp
AT hydet expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp
AT harrisonp expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp
AT kleinmanj expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp
AT lipskab expressionofagrm3splicevariantisincreasedinthedorsolateralprefrontalcortexofindividualscarryingaschizophreniarisksnp